Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:SHAK
NYSE:SHAKHospitality

Why Shake Shack (SHAK) Is Up 10.6% After Unveiling AI-Powered Project Catalyst Modernization Initiative

In April 2026, Shake Shack Inc. launched Project Catalyst, a broad technology push to modernize restaurant systems, build its first loyalty program, expand AI tools, and strengthen data capabilities as it works toward 1,500 Company-operated Shacks. By partnering with cloud-native platform Qu to overhaul its POS and kitchen display systems, Shake Shack is betting that better data, faster ordering, and AI-driven insights can tighten operations while deepening guest engagement across both...
BME:REP
BME:REPOil and Gas

Is Repsol’s Reaffirmed €6 Billion Cash Flow Guidance After Outages Altering The Investment Case For Repsol (BME:REP)?

Repsol reported past Q2 2025 adjusted income of €702 million, an 8% quarter-over-quarter increase, with operating cash flow rising 50% to €1.70 billion despite a €175 million EBIT impact from Iberian power outages. The company also reaffirmed its full-year guidance for €6.00 billion in operating cash flow, signalling management’s confidence in cash generation even after recent disruptions. We’ll now examine how this reaffirmed €6.00 billion operating cash flow guidance could influence...
NasdaqGS:PRDO
NasdaqGS:PRDOConsumer Services

A Look At Perdoceo Education (PRDO) Valuation After Its Recent Share Price Momentum

Why Perdoceo Education Is On Investors’ Radar Perdoceo Education (PRDO) has drawn fresh attention after a period of solid share price movement, with returns over the past month and past 3 months outpacing its longer term performance profile. See our latest analysis for Perdoceo Education. The recent momentum looks strong, with a 10.29% 1 month share price return and 20.17% 3 month share price return feeding into a 30.41% year to date share price return and a 52.79% 1 year total shareholder...
NYSE:AGO
NYSE:AGOInsurance

Assessing Assured Guaranty’s Valuation After Recent Share Price Weakness

What Assured Guaranty’s Recent Performance Tells Investors Assured Guaranty (AGO) has drawn fresh attention after a period where the share price showed a 4.3% decline over the past month and a 9.1% decline over the past 3 months, inviting a closer look at current valuation and fundamentals. See our latest analysis for Assured Guaranty. While the recent 30 day and 90 day share price returns of 4.3% and 9.1% declines suggest fading momentum in the short term, the 1 year and 5 year total...
NYSE:SAM
NYSE:SAMBeverage

Is Boston Beer (SAM) Quietly Recasting Its Brand With Sun Cruiser’s Non‑Carbonated Vodka RTDs?

In early April 2026, Sun Cruiser, part of Boston Beer Company, launched its Sun Cruiser White Tea + Vodka line across select U.S. states, offering a non‑carbonated, low‑calorie, vodka-based ready-to-drink variety pack in four white tea-inspired flavors. This move highlights Boston Beer’s push into “better-for-you,” non-carbonated spirits-based RTDs, an area where differentiation and early brand recognition can be important for long-term consumer traction. We’ll now examine how this...
TSE:8001
TSE:8001Trade Distributors

The Bull Case For ITOCHU (TSE:8001) Could Change Following ERI Japan Venture And Major Buyback

In late March 2026, ERI announced a 50-50 venture with ITOCHU to launch ERI Japan, bringing advanced e-waste recycling and IT asset disposition services to the Japanese market later in 2026, while ITOCHU also completed a ¥19,999.85 million share repurchase and held a board meeting on a tender offer recommendation. This move highlights how ITOCHU is pairing capital returns with exposure to circular economy solutions, using ERI’s technology and its own global networks to expand in...
NYSE:PNFP
NYSE:PNFPBanks

Can Pinnacle Financial Partners (PNFP) Turn Net Cash Strength Into Profits Amid Rising Costs?

Pinnacle Financial Partners recently expanded its Louisville Lakeview office by hiring David Krebs, a veteran commercial banker with more than 25 years of relationship-management experience from Stock Yards Bank & Trust. At the same time, fresh analysis points to rising expenses, a relatively low 3.2% net interest margin and slowing tangible book value growth, prompting questions about how efficiently Pinnacle can convert its sizeable US$877.4 million net cash position into sustainable...
NYSE:HCI
NYSE:HCIInsurance

Is HCI’s Record 2025 Earnings And Exzeo IPO Altering The Investment Case For HCI Group (HCI)?

HCI Group recently reported a strong Q4, with revenues rising 52.1% year on year, beating analyst expectations and capping a year of record 2025 earnings and shareholder returns, alongside the successful IPO of its technology platform, Exzeo. The combination of rapidly growing revenue and the separation of Exzeo as a listed technology platform raises fresh questions about how HCI Group’s business mix and earnings profile could evolve. Next, we’ll examine how HCI Group’s record 2025 earnings...
TSX:EQX
TSX:EQXMetals and Mining

Is It Too Late To Reassess Equinox Gold (TSX:EQX) After Its Sharp One Year Surge?

If you are wondering whether Equinox Gold is still attractively priced after its recent run, or if you might be late to the story, this article walks through what the current share price could imply about value. The stock last closed at US$20.33, with a 12.8% return over the past 7 days, a 9.9% decline over 30 days, and returns of 7.9% year to date, 148.2% over 1 year, 173.5% over 3 years, and 90.5% over 5 years. Recent headlines around Equinox Gold have focused on its position in the gold...
NYSE:BW
NYSE:BWElectrical

Why Babcock & Wilcox Enterprises (BW) Is Up 26.8% After Major AI Data Center Power Deal

Babcock & Wilcox Enterprises recently secured a US$2.40 billion design-build contract with Base Electron to deliver 1.2 gigawatts of natural gas-fired power generation for AI data center campuses, lifting its reported operations backlog to US$2.80 billion. The deal has positioned Babcock & Wilcox as a meaningful supplier to the fast-growing AI data center power market, while also drawing regulatory scrutiny over how the contract was structured and its implications for a major...
NYSE:WH
NYSE:WHHospitality

Should Wyndham’s New CFO and Franchise Milestones Shape a Rethink of Its Growth Strategy (WH)?

Wyndham Hotels & Resorts has recently reshaped its leadership team, appointing Amit Sripathi as Chief Financial Officer and David Wilner as Chief Development Officer – North America, while also marking expansion milestones such as surpassing 100 Trademark Collection hotels in the US and more than 100 properties across Mexico. Together, these leadership changes and portfolio milestones highlight Wyndham’s emphasis on disciplined franchise growth and deeper penetration in both domestic and key...
NasdaqGS:HTO
NasdaqGS:HTOWater Utilities

Does Surging Short Interest And Insider Moves Change The Bull Case For H2O America (HTO)?

In 2025, former H2O America President, CEO, and Chairman Eric W. Thornburg received total compensation of US$3,065,270, while the current CEO recently sold shares on the open market and institutional investors shifted their holdings. At the same time, short interest in H2O America jumped very large in March, with a significant portion of shares now sold short, pointing to a sharper focus on potential operational or financial issues. Analyst Ross Fowler at BofA Securities continues to rate...
NasdaqGS:BWIN
NasdaqGS:BWINInsurance

What Baldwin Insurance Group (BWIN)'s Insider Buy And Analyst Upgrade Signal For Shareholders

In early March 2026, Baldwin Insurance Group reported fourth-quarter 2025 earnings that exceeded analyst expectations despite a slight revenue shortfall, while director Paul Eugene Sparks purchased US$1,000,000 of Class A Common Stock and Raymond James upgraded its rating on the shares to Strong Buy. Taken together, the insider share purchase and analyst upgrade underscore growing confidence in Baldwin Insurance Group’s business quality and earnings resilience, even as revenue growth came in...
NasdaqGS:IREN
NasdaqGS:IRENSoftware

IREN (IREN) Is Up 11.1% After Massive AI GPU Pivot And US$6B Equity Plan Unveiled

In recent weeks, Iris Energy (IREN) accelerated its pivot from Bitcoin mining to GPU-powered AI cloud services, securing over 50,000 Nvidia B300 GPUs and advancing plans to leverage a secured 4.5GW power portfolio for large-scale data center expansion. At the same time, a very large US$6.00 billion at-the-market equity program and new U.S. tariffs on AI chips have raised questions about dilution, hardware costs, and execution risk as the company targets an AI cloud-focused future. Now we’ll...
NYSE:MUSA
NYSE:MUSASpecialty Retail

What Murphy USA (MUSA)'s CFO Appointment and Governance Moves Mean For Shareholders

On March 26, 2026, Murphy USA announced that long-time finance executive Donald R. Smith, Jr. had been appointed permanent Senior Vice President, Chief Financial Officer and Treasurer, while also disclosing his compensation terms and related governance details. This leadership change highlights the board’s preference for continuity and internal expertise at a time when some shareholders are also pushing for greater influence over corporate governance. We’ll now examine how Smith’s elevation...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

How Bio-Techne's Spatial Biology COMET Expansion (TECH) Has Changed Its Investment Story

In March 2026, Bio-Techne expanded its COMET spatial biology portfolio with new SPYRE Focus Panels, SPYRE Amplification Kits, and upgraded HORIZON image analysis software to enhance automated, modular tissue analysis workflows from assay design through interpretation. This expansion deepens Bio-Techne’s footprint in high-content spatial biology by combining validated, modular antibody panels with seqLA-based signal amplification to help researchers extract richer insights from scarce tissue...
NasdaqCM:RGC
NasdaqCM:RGCPharmaceuticals

Assessing Regencell Bioscience Holdings (NasdaqCM:RGC) Valuation After New Equity Offering Plans

Why Regencell Bioscience Holdings (NasdaqCM:RGC) is in Focus Right Now Regencell Bioscience Holdings (NasdaqCM:RGC) has filed a US$500 million follow on equity offering of common stock as an at the market program, shortly after registering a shelf for its ordinary shares. See our latest analysis for Regencell Bioscience Holdings. The equity offering headlines come after a sharp shift in sentiment, with a 7 day share price return of 32.15% and a 30 day share price return of 32.03%, set against...
NYSE:TPB
NYSE:TPBTobacco

A Look At Turning Point Brands (TPB) Valuation After FDA Delays On Nicotine Pouch Approvals

Turning Point Brands (TPB) is back in focus after reports that the FDA is delaying approvals for its nicotine pouch products, raising fresh questions around regulation, youth access, and future product launches. See our latest analysis for Turning Point Brands. The regulatory headlines have hit sentiment hard, with a 30 day share price return showing an 18.51% decline and a 90 day share price return showing a 27.63% decline, even after the recent 3.51% one day gain to US$74.69. However, the 1...
NYSE:KVUE
NYSE:KVUEPersonal Products

Kenvue’s Dermatologist-Focused Skincare Push Might Change The Case For Investing In Kenvue (KVUE)

At the March 27–31, 2026 American Academy of Dermatology meeting in Denver, Kenvue’s Neutrogena, Aveeno, and Rogaine brands showcased new science-backed products, research on hydration, acne care, and sun protection, and educational initiatives for dermatology professionals and residents. The breadth of clinical data, including work on advanced UV filters like BEMT and skin-barrier-supportive formulations, highlights how Kenvue is tying product innovation directly to evolving dermatologist...
NYSE:NNI
NYSE:NNIConsumer Finance

Does Nelnet’s New Long-Dated Credit Line Reveal a Shift in Funding Strategy for NNI?

Nelnet, Inc. recently entered into a new Credit Agreement for a US$435 million unsecured line of credit maturing on March 31, 2031, while terminating its prior US$495 million facility that was due in 2026 and carried no outstanding balance at the time. This refreshed, long-dated borrowing capacity, backed by customary financial covenants and subsidiary guarantees, underscores the company’s emphasis on maintaining flexible funding for general corporate purposes. With this extended US$435...
NYSE:DINO
NYSE:DINOOil and Gas

Does Repeated Earnings Outperformance Reshape The Profit Narrative For HF Sinclair (DINO)?

Recently, HF Sinclair reported quarterly earnings of US$1.20 per share, very large above the consensus estimate of US$0.44, extending a multi-quarter pattern of outperforming analyst expectations. This repeated earnings outperformance has led analysts to grow more optimistic about the company’s near‑term profit potential, especially given its integrated refining and fuel production footprint. Building on this recent history of substantial earnings surprises, we’ll explore how strengthened...
CPSE:CARL B
CPSE:CARL BBeverage

Carlsberg (CPSE:CARL B) Valuation Check After Recent Share Price Gains Without Clear News Catalyst

Carlsberg stock reaction and recent performance snapshot Carlsberg (CPSE:CARL B) has moved without a clear single news catalyst. This has left investors to focus on recent share performance, valuation signals and the company’s latest reported financial profile. Over the past month, the share price shows a return of about 10%, while the past 3 months are roughly flat. Year to date, Carlsberg’s total return is around 1% lower, with a 1 year total return close to 1%. See our latest analysis for...
NasdaqGS:ICLR
NasdaqGS:ICLRLife Sciences

How ICON’s AI-Focused Partnership with Advarra Could Reshape ICLR’s Clinical Trial Efficiency Narrative

In March 2026, ICON plc and Advarra announced a partnership to create a connected, “research-ready” site network that links ICON’s clinical trial solutions with Advarra’s widely used site technologies to reduce administrative friction, speed up study startup, and expand trial access globally. This collaboration gives ICON access to Advarra’s data and AI-driven operational intelligence, potentially refining protocol design, forecasting, and site selection by aligning studies more closely with...
NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

Why Arcutis Biotherapeutics (ARQT) Is Up 10.9% After Positive Infant Atopic Dermatitis Trial Data And What's Next

At the 2026 American Academy of Dermatology meeting in Denver, Arcutis Biotherapeutics reported Phase 2 INTEGUMENT-INFANT data showing ZORYVE cream 0.05% improved signs and symptoms of mild to moderate atopic dermatitis in infants aged 3 to less than 24 months, with a safety and tolerability profile consistent with prior pediatric trials. Beyond reinforcing ZORYVE’s safety across very young patients, the new data underpin Arcutis’ plan to file a supplemental New Drug Application in 2026,...